Digital PCR (dPCR) and Real-Time PCR (qPCR) Market

Market Synopsis:

Digital dPCR and (qPCR) Market was valued at 5,341.60 USD Million in 2021 and is projected to reach a value of 8,860.22 USD Million by 2028 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 8.8% over the forecast period.

The growing market penetration in the emerging countries and shifting of consumers' opinions from plant-delivered drugs to genome-based drugs are projected to boost the market growth during the forecast period. Growth in the occurrence of target diseases globally attached with the verified efficiency of Digital PCR (dPCR) and Real-Time PCR (qPCR) analysis in the diagnosis and the valuation of disease-causing microbes, which will drive the utilization of clinical diagnostic tests including Digital PCR (dPCR) and Real-Time PCR (qPCR) analysis which is expected to contribute to the growth of the market during the forecast period. The rising technological advancements in PCR technologies, growing investments, funds, and grants are expected to increase the demand for Digital PCR (dPCR) in the upcoming years. Moreover, the rising incidents of genetic disorders, target infectious diseases, increasing use of biomarker profiling for disease diagnostics, and the successful completion of the Human Genome Project are the major factors driving the growth of the Digital PCR (dPCR) and Real-Time PCR (qPCR) Market during the forecast period. Furthermore, the transition of the plant to genome-based drug discovery is expected to offer the opportunity for the growth of the digital PCR (dPCR) and Real-Time PCR (qPCR) Market in the upcoming years. Additionally, the technical limitations related to PCR and the increased cost of PCR devices are projected to hinder the growth of the Digital PCR (dPCR) and Real-Time PCR (qPCR) market during the forecast period.

Market Segmentation:

The Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is segmented based on Product & Services, Application, End-User, and Region. Based on Product & Services, the market is further segmented into qPCR Products & Services, qPCR Reagents & Consumables, qPCR Instruments, qPCR Software & Services, dPCR Products & Services, dPCR Instruments, dPCR Reagents & Consumables, and dPCR Software & Services. Furthermore, based on Application, the market is segmented as qPCR Applications, Clinical Applications, Research Applications, Forensic Applications, dPCR Applications, Clinical Applications, Research Applications, and Forensic Applications. In addition, based on End-Users, the market is segmented as qPCR End User, Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Clinical Research Organizations, Pharmaceutical & Biotechnology Companies, and Forensic Laboratories.

The Hospital & Diagnostic Centers acquires the largest share of the Digital PCR (dPCR) and Real-Time PCR (qPCR) Market

The Hospital & Diagnostic Center segment is expected to dominate the Digital PCR (dPCR) and Real-Time PCR (qPCR) Market during the forecast period owing to the increasing availability of qPCR reagents in the market. In the Application of clinical diagnostic, and the ongoing expansion of healthcare infrastructure across emerging countries. The high prevalence and incidence of target diseases like HIV-AIDS, Cancer, malaria, and tuberculosis are expected to increase the demand for hospital and diagnostic centers in the Digital PCR (dPCR) and Real-Time PCR (qPCR) market. The increasing awareness among End-Users associated with the benefits provided by qPCR ineffective and rapid disease diagnosis is expected to drive the Digital PCR (dPCR) and Real-Time PCR (qPCR) Market growth in coming years.

The Clinical segment of dPCR is projected to grow at the highest CAGR during the Forecast Period

The clinical segment is expected to grow at the highest Compound Annual Growth Rate (CAGR) during the forecast period. The growth of the clinical segment is primarily attributed to the better precision, increased device sensitivity, and complete qualification of the target molecule. The increasing adoption of dPCR among Hospital & Diagnostic Centers and increasing cases of AIDS and cancer are expected to increase the demand for dPCR in the coming years.

North America is projected to hold the largest share of Digital PCR (dPCR) and Real-Time PCR (qPCR) during the forecast period

The growth in the North American Digital PCR (dPCR) and Real-Time PCR (qPCR) Market is mainly attributed to the increasing adoption of advanced and original genomic analysis products including innovative Digital PCR (dPCR) and Real-Time PCR (qPCR) products. The growth in the availability of Research and Development (R&D) funding for genomic research connected with the robust research infrastructure available in the region is increasing the growth of the Digital PCR (dPCR) and Real-Time PCR (qPCR) market in North America. North America is growing due to the early commercialization of Digital PCR (dPCR) and Real-Time PCR (qPCR) products as compared with the other regions. The North American region including Canada and the United Kingdom is projected to be the largest market owing to the increased funding for Digital PCR (dPCR) and Real-Time PCR (qPCR) technologies.

Asia Pacific region is projected to grow at the highest Compound Annual Growth Rate (CAGR) owing to rapidly developing economies, a rise in the government support for life science research, growth in the aging population connected with the growth in the incidence of genetic diseases, growing research, and the clinical trial out-sourcing from the region which is expected to increase the demand of Digital PCR (dPCR) and Real-Time PCR (qPCR) in the Asia Pacific region.

Competitive Landscape:

The key players in the Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market include- Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Agilent Technologies (US), Analytik Jena AG (Germany), Becton, Dickinson and Company (US), bioMérieux SA (France), Danaher Corporation (US), Eppendorf (Germany), Fluidigm Corporation (US), Merck KGaA (Germany), QIAGEN N.V. (German), Takara Bio (Japan), Meridian Bioscience (US), Promega Corporation (US), Enzo Life Sciences, Inc. (US), Bioneer (South Korea), ELITech Group (France), Quidel Corporation (US) and others.

Segmentation of the Global Digital PCR (dPCR) and Real-Time PCR (qPCR) Market: